Benjamin Kalsmith is a Cardiology physician. OpenAlex indexes 8 publications with 397 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5750 Centre Ave
Suite 510
Pgh, PA 15206
Telephone
412-924-1100Registry record last updated 29 Jul 2014.
Industry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202546 payments$79,182openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202566 payments$70,150openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202577 payments$41,959openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.9%Beta blocker17.8%Metoprolol Succinate37%Metoprolol Tartrate29%Carvedilol22%Sotalol6%Atenolol4%Propranolol Hcl Er2%Nebivolol Hcl1%Part D<11 patientsStatin13.4%Atorvastatin Calcium60%Rosuvastatin Calcium30%Simvastatin6%Pravastatin Sodium4%Part D≥345 patients+ 25 more classes in this area
Blood & clotting
22.1%Factor Xa inhibitor11.6%Eliquis93%Xarelto7%Part D≥359 patientsP2Y12 inhibitor9.2%Clopidogrel93%Brilinta6%Prasugrel Hcl1%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.5%SGLT2 inhibitor2.4%Jardiance89%Farxiga11%Part D<11 patientsPotassium supplement1.1%Potassium Chloride89%Klor-Con M2011%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
Circulation Heart Failure
2010 - RISK OF STROKE AND DEATH IN PATIENTS WITH SYMPTOMATIC CEREBROVASCULAR DISEASE UNDERGOING HEART TRANSPLANTATION: AN ANALYSIS OF THE UNITED NETWORK FOR ORGAN SHARING REGISTRY
Journal of the American College of Cardiology
2010 - Time‐Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy
Journal of Cardiovascular Electrophysiology
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”